The difference doesn’t come down to one single factor.
Comments that try to reduce population-scale differences to a single factor, like access to healthcare, are overly reductive. When it comes to obesity (not using being overweight, but truly past the obese threshold) you don’t need a doctor to inform you that it’s unhealthy.
The reductive claims about access to healthcare are also ignoring the fact that people in the US do actually use a lot of healthcare. The rate of GLP-1 use in America for weight loss is around 1 in 8 people, which is significantly higher than anywhere in Europe last time I checked. Obviously the higher obesity rate contributes to higher usage, but it demonstrates that many obese people in the United States are not lacking access to health care.
Comments that try to reduce population-scale differences to a single factor, like access to healthcare, are overly reductive. When it comes to obesity (not using being overweight, but truly past the obese threshold) you don’t need a doctor to inform you that it’s unhealthy.
The reductive claims about access to healthcare are also ignoring the fact that people in the US do actually use a lot of healthcare. The rate of GLP-1 use in America for weight loss is around 1 in 8 people, which is significantly higher than anywhere in Europe last time I checked. Obviously the higher obesity rate contributes to higher usage, but it demonstrates that many obese people in the United States are not lacking access to health care.